Florentine E F Timmer
Overview
Explore the profile of Florentine E F Timmer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Lei S, Puijk R, Dijkstra M, Schulz H, Vos D, De Vries J, et al.
Lancet Oncol
. 2025 Jan;
26(2):187-199.
PMID: 39848272
Background: For patients with small-size colorectal liver metastases, growing evidence suggests thermal ablation to be associated with fewer adverse events and faster recovery than resection while also challenging resection in...
2.
Geboers B, Scheltema M, Jung J, Bakker J, Timmer F, Cerutti X, et al.
BJU Int
. 2024 Aug;
135(2):319-328.
PMID: 39101639
Objectives: To prospectively compare systemic anti-tumour immune responses induced by irreversible electroporation (IRE) and robot-assisted radical prostatectomy (RARP) in patients with localised intermediate-risk prostate cancer (PCa). Patients And Methods: Between...
3.
Vos D, Ruarus A, Timmer F, Geboers B, Bagla S, Belfiore G, et al.
Semin Intervent Radiol
. 2024 Jul;
41(2):176-219.
PMID: 38993594
Since no uniform treatment protocol for pancreatic irreversible electroporation (IRE) exists, the heterogeneity throughout literature complicates the comparison of results. To reach agreement among experts, a consensus study was performed....
4.
Timmer F, Geboers B, Scheffer H, Bruynzeel A, Meijerink M
Lancet Gastroenterol Hepatol
. 2024 Jul;
9(8):687-688.
PMID: 38971162
No abstract available.
5.
Miedema I, Pouw J, Kwakman A, Zwezerijnen G, Huisman M, Timmer F, et al.
J Immunother Cancer
. 2024 Jun;
12(6).
PMID: 38886117
Introduction: Immune checkpoint inhibitors (ICIs) can elicit anticancer immune responses, but predictive biomarkers are needed. We measured programmed death ligand 1 (PD-L1) expression in organs and lymph nodes using F-BMS-986192...
6.
Puijk R, Dijkstra M, van der Lei S, Schulz H, Vos D, Timmer F, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539527
With the rapidly evolving field of image-guided tumor ablation, there is an increasing demand and need for tools to optimize treatment success. Known factors affecting the success of (non-)thermal liver...
7.
Schulz H, Dijkstra M, van der Lei S, Vos D, Timmer F, Puijk R, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539433
Background: The simultaneous presence of colorectal liver metastases (CRLMs) and extrahepatic metastases in patients with colorectal cancer (CRC) can be considered a relative contraindication for local treatment with curative intent....
8.
Timmer F, Geboers B, Ruarus A, Vroomen L, Schouten E, van der Lei S, et al.
Lancet Gastroenterol Hepatol
. 2024 Mar;
9(5):448-459.
PMID: 38513683
Background: Pancreatic ductal adenocarcinoma is an aggressive disease with a dismal prognosis. Stage III locally advanced pancreatic cancer is considered unresectable and current palliative chemotherapy regimens only modestly improve survival....
9.
Dijkstra M, Kuiper B, Schulz H, van der Lei S, Puijk R, Vos D, et al.
Cardiovasc Intervent Radiol
. 2023 Nov;
47(2):253-262.
PMID: 37943351
Purpose: The objective of the COLLISION RELAPSE trial is to prove or disprove superiority of neoadjuvant systemic therapy followed by repeat local treatment (either thermal ablation and/or surgical resection), compared...
10.
Dijkstra M, van der Lei S, Puijk R, Schulz H, Vos D, Timmer F, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686622
Purpose: Thermal ablation is widely recognized as the standard of care for small-size unresectable colorectal liver metastases (CRLM). For larger CRLM safety, local control and overall efficacy are not well...